Smartlab Europe

Drug Research

Ypsomed collaborates with SCHOTT and Lonza to develop a comprehensive solution for combination products based on patch injectors

Ypsomed advances its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT, one of the leading suppliers of pharmaceutical primary packaging, and Lonza, a leading global partner of the pharmaceutical and biotechnology industry for the...

Stelis starts next phase of investment into its biologics manufacturing facility

Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma, has started the next phase of its continued investment program after having already invested more than $100 million into its facilities in Bangalore, India. The latest phase...

Transcenta and Merck Announce a Strategic Collaboration at CIIE to Advance Continuous Biomanufacturing

Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics at CIIE. “To...

Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration

Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, announced that they have entered into a discovery collaboration to develop next-generation CAR-T...

Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China

Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug...

Novavax Announces Facility Expansion to Support Global Vaccine Development

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland campus to accommodate the company’s rapid growth as it works to develop its candidate vaccine against COVID-19 and advance its...

aTyr Pharma Announces Research Collaboration with Medical University of South Carolina

aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »